162 related articles for article (PubMed ID: 9015278)
1. Efficient production of JC virus in SVG cells and the use of purified viral antigens for analysis of specific humoral and cellular immune response.
Frye S; Trebst C; Dittmer U; Petry H; Bodemer M; Hunsmann G; Weber T; Lüke W
J Virol Methods; 1997 Jan; 63(1-2):81-92. PubMed ID: 9015278
[TBL] [Abstract][Full Text] [Related]
2. Comparison of cell culture-grown JC virus (primary human fetal glial cells and the JCI cell line) and recombinant JCV VP1 as antigen for the detection of anti-JCV antibody by haemagglutination inhibition.
Knowles WA; Sasnauskas K
J Virol Methods; 2003 Apr; 109(1):47-54. PubMed ID: 12668267
[TBL] [Abstract][Full Text] [Related]
3. Synthetic antibodies and peptides recognizing progressive multifocal leukoencephalopathy-specific point mutations in polyomavirus JC capsid viral protein 1.
Chen G; Gorelik L; Simon KJ; Pavlenco A; Cheung A; Brickelmaier M; Chen LL; Jin P; Weinreb PH; Sidhu SS
MAbs; 2015; 7(4):681-92. PubMed ID: 25879139
[TBL] [Abstract][Full Text] [Related]
4. Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope.
Koralnik IJ; Du Pasquier RA; Kuroda MJ; Schmitz JE; Dang X; Zheng Y; Lifton M; Letvin NL
J Immunol; 2002 Jan; 168(1):499-504. PubMed ID: 11751998
[TBL] [Abstract][Full Text] [Related]
5. Antibody against synthetic multiple antigen peptides (MAP) of JC virus capsid protein (VP1) without cross reaction to BK virus: a diagnostic tool for progressive multifocal leukoencephalopathy.
Aoki N; Mori M; Kato K; Sakamoto Y; Noda K; Tajima M; Shimada H
Neurosci Lett; 1996 Feb; 205(2):111-4. PubMed ID: 8907329
[TBL] [Abstract][Full Text] [Related]
6. Reappraisal of progressive multifocal leukoencephalopathy due to simian virus 40.
Stoner GL; Ryschkewitsch CF
Acta Neuropathol; 1998 Sep; 96(3):271-8. PubMed ID: 9754960
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning and expression of major structural protein VP1 of the human polyomavirus JC virus: formation of virus-like particles useful for immunological and therapeutic studies.
Goldmann C; Petry H; Frye S; Ast O; Ebitsch S; Jentsch KD; Kaup FJ; Weber F; Trebst C; Nisslein T; Hunsmann G; Weber T; Lüke W
J Virol; 1999 May; 73(5):4465-9. PubMed ID: 10196348
[TBL] [Abstract][Full Text] [Related]
8. JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.
Koralnik IJ; Du Pasquier RA; Letvin NL
J Virol; 2001 Apr; 75(7):3483-7. PubMed ID: 11238876
[TBL] [Abstract][Full Text] [Related]
9. A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.
Lee P; Plavina T; Castro A; Berman M; Jaiswal D; Rivas S; Schlain B; Subramanyam M
J Clin Virol; 2013 Jun; 57(2):141-6. PubMed ID: 23465394
[TBL] [Abstract][Full Text] [Related]
10. Human anti-JC virus serum reacts with native but not denatured JC virus major capsid protein VP1.
Wang M; Tzeng TY; Fung CY; Ou WC; Tsai RT; Lin CK; Tsay GJ; Chang D
J Virol Methods; 1999 Mar; 78(1-2):171-6. PubMed ID: 10204707
[TBL] [Abstract][Full Text] [Related]
11. Detection of JC virus-specific immune responses in a novel humanized mouse model.
Tan CS; Broge TA; Seung E; Vrbanac V; Viscidi R; Gordon J; Tager AM; Koralnik IJ
PLoS One; 2013; 8(5):e64313. PubMed ID: 23700470
[TBL] [Abstract][Full Text] [Related]
12. Brief Report: Decreased JC Virus-Specific Antibody-Dependent Cellular Cytotoxicity in HIV-Seropositive PML Survivors.
Tan CS; Ghofrani J; Geiger E; Koralnik IJ; Jost S
J Acquir Immune Defic Syndr; 2019 Oct; 82(2):220-224. PubMed ID: 31513076
[TBL] [Abstract][Full Text] [Related]
13. Production of the antigen and the antibody of the JC virus major capsid protein VP1.
Chang D; Liou ZM; Ou WC; Wang KZ; Wang M; Fung CY; Tsai RT
J Virol Methods; 1996 May; 59(1-2):177-87. PubMed ID: 8793846
[TBL] [Abstract][Full Text] [Related]
14. A monoclonal antibody to SV40 large T-antigen labels a nuclear antigen in JC virus-transformed cells and in progressive multifocal leukoencephalopathy (PML) brain infected with JC virus.
Stoner GL; Ryschkewitsch CF; Walker DL; Soffer D; Webster HD
J Neuroimmunol; 1988 Mar; 17(4):331-45. PubMed ID: 2828425
[TBL] [Abstract][Full Text] [Related]
15. Human iPS cell-derived astrocytes support efficient replication of progressive multifocal leukoencephalopathy-type JC polyomavirus.
Shimbo E; Nukuzuma S; Tagawa YI
Biochem Biophys Res Commun; 2020 Dec; 533(4):983-987. PubMed ID: 33008586
[TBL] [Abstract][Full Text] [Related]
16. Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding.
Maginnis MS; Ströh LJ; Gee GV; O'Hara BA; Derdowski A; Stehle T; Atwood WJ
mBio; 2013 Jun; 4(3):e00247-13. PubMed ID: 23760462
[TBL] [Abstract][Full Text] [Related]
17. Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy.
Lima MA; Marzocchetti A; Autissier P; Tompkins T; Chen Y; Gordon J; Clifford DB; Gandhi RT; Venna N; Berger JR; Koralnik IJ
J Virol; 2007 Apr; 81(7):3361-8. PubMed ID: 17229701
[TBL] [Abstract][Full Text] [Related]
18. Overview of the cellular immunity against JC virus in progressive multifocal leukoencephalopathy.
Koralnik IJ
J Neurovirol; 2002 Dec; 8 Suppl 2():59-65. PubMed ID: 12491153
[TBL] [Abstract][Full Text] [Related]
19. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy.
Weber T; Trebst C; Frye S; Cinque P; Vago L; Sindic CJ; Schulz-Schaeffer WJ; Kretzschmar HA; Enzensberger W; Hunsmann G; Lüke W
J Infect Dis; 1997 Jul; 176(1):250-4. PubMed ID: 9207375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
